RANKINGS

POPULAR STOCKS

Samsung Biologics Co.,Ltd.

KSE:207940.KS

Location

South Korea

Market Cap

USD 51.98 B

Share Price

USD 733.27

Avg Daily Volume

76,833

Change (1 day)

-0.09%

Change (1 year)

40.68%

Change (YTD)

14.30%

Samsung Biologics Co.,Ltd. Current Ratio for the year ending December 31, 2024: 1.03

Samsung Biologics Co.,Ltd. Current Ratio is 1.03 for the year ending December 31, 2024, a -22.29% change year over year. Current ratio represents the short-term liquidity measurement, showing current assets' coverage of liabilities. Higher ratio implies better ability to meet short-term obligations.
  • Samsung Biologics Co.,Ltd. Current Ratio for the year ending December 31, 2023 was 1.33, a -14.00% change year over year.
  • Samsung Biologics Co.,Ltd. Current Ratio for the year ending December 31, 2022 was 1.54, a -39.43% change year over year.
  • Samsung Biologics Co.,Ltd. Current Ratio for the year ending December 31, 2021 was 2.55, a -14.21% change year over year.
  • Samsung Biologics Co.,Ltd. Current Ratio for the year ending December 31, 2020 was 2.97, a 51.31% change year over year.
Key data
Date Current Ratio Interest Coverage Ratio Return on Capital Employed (ROCE) Return on Equity (ROE)
Market news
KSE: 207940.KS

Samsung Biologics Co.,Ltd.

CEO Mr. John Chongbo Rim
IPO Date Nov. 11, 2016
Location South Korea
Headquarters 300, Songdo Bio-daero
Employees 4,770
Sector 🏥 Health Care
Industries
Biotechnology
🔬 Clinical Trials
💳 Credit Cards & Payments
🏥 Hospitals & Clinics
💰 Venture Capital
Description

Samsung Biologics Co.,Ltd. engages in the contract manufacturing organization (CMO) business for biopharmaceuticals products. The company operates in two segments, CMO and Contract Development Organization (CDO). It is involved in the provision of CDO services, including cell line development, upstream and downstream processes, and analytical methods and formulations. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the development and commercialization of biosimilar drugs; and manufactures mammalian cell-based antibody drugs. The company was founded in 2011 and is headquartered in Incheon, South Korea.

Similar companies

MRK

Merck & Co., Inc.

USD 78.83

-1.05%

SHL.DE

Siemens Healthineers AG

USD 54.80

0.08%

BIM.PA

bioMérieux S.A.

USD 140.05

0.52%

BAX

Baxter International Inc.

USD 30.50

-0.36%

RGC

Regencell Bioscience Holdings Limited

USD 20.19

-7.09%

2196.HK

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

USD 2.06

0.53%

CTEC.L

ConvaTec Group Plc

USD 3.97

0.12%

GMED

Globus Medical, Inc.

USD 58.82

1.08%

002653.SZ

Haisco Pharmaceutical Group Co., Ltd.

USD 5.88

-0.30%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 7.86

-1.68%

688617.SS

APT Medical Inc.

USD 41.08

1.04%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.54

-0.25%

600161.SS

Beijing Tiantan Biological Products Co., Ltd.

USD 2.68

-0.44%

TMDX

TransMedics Group, Inc.

USD 130.06

1.15%

600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

USD 4.04

2.16%

000739.SZ

Apeloa Pharmaceutical Co.,Ltd

USD 1.96

0.62%

JUBLPHARMA.NS

Jubilant Pharmova Limited

USD 13.77

0.05%

600420.SS

Shanghai Shyndec Pharmaceutical Co., Ltd.

USD 1.49

0.45%

0853.HK

MicroPort Scientific Corporation

USD 1.11

1.19%

NVCR

NovoCure Limited

USD 17.10

-1.33%

QDEL

QuidelOrtho Corporation

USD 28.70

2.10%

603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd.

USD 4.09

3.84%

603567.SS

Heilongjiang ZBD Pharmaceutical Co., Ltd.

USD 1.66

-0.44%

300026.SZ

Tianjin Chase Sun Pharmaceutical Co.,Ltd

USD 0.52

0.52%

688016.SS

Shanghai MicroPort Endovascular MedTech Co., Ltd.

USD 12.27

0.36%

ABBV

AbbVie Inc.

USD 186.79

0.76%

NOVO-B.CO

Novo Nordisk A/S

USD 67.40

-0.61%

RO.SW

Roche Holding AG

USD 346.81

1.67%

ABT

Abbott Laboratories

USD 133.67

-2.71%

NOVN.SW

Novartis AG

USD 119.96

1.87%

AZN.L

AstraZeneca PLC

USD 139.42

-0.41%

TMO

Thermo Fisher Scientific Inc.

USD 412.12

0.36%

BSX

Boston Scientific Corporation

USD 104.58

0.28%

AMGN

Amgen Inc.

USD 279.11

-0.44%

PFE

Pfizer Inc.

USD 24.24

-0.08%

GILD

Gilead Sciences, Inc.

USD 107.62

1.59%

SAN.PA

Sanofi

USD 96.29

0.40%

VRTX

Vertex Pharmaceuticals Incorporated

USD 443.40

-0.54%

BMY

Bristol-Myers Squibb Company

USD 46.65

-0.06%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 52.04

-0.89%

GSK.L

GSK plc

USD 19.17

0.64%

CSL.AX

CSL Limited

USD 154.14

-1.86%

COR

Cencora, Inc.

USD 296.58

1.46%

REGN

Regeneron Pharmaceuticals, Inc.

USD 521.00

0.14%

MRK.DE

MERCK Kommanditgesellschaft auf Aktien

USD 130.63

1.54%

BDX

Becton, Dickinson and Company

USD 169.97

-0.54%

600276.SS

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.21

-0.69%

4502.T

Takeda Pharmaceutical Company Limited

USD 30.27

0.35%

ALNY

Alnylam Pharmaceuticals, Inc.

USD 318.25

-1.15%

UCB.BR

UCB SA

USD 197.49

0.30%

StockViz Staff

June 27, 2025

Any question? Send us an email